CloudMD

DOC-X

Analysis and Opinions about DOC-X

Signal
Opinion
Expert
BUY
BUY
September 1, 2020

WELL Health vs. Cloud MD, and buy the warrants? Different companies in the same sector. He owns both and expects both to excel in the coming year. Cloud MD just released earnings, not as strong as he expected, but talked about future catalysts coming in the fall. WELL just announced an acquisition and got financing from their biggest shareholder, Lee Ka-Shing. Both are equally good. Warrants: you could do this, but the challenge is that both stocks have enjoyed huge runs and profit-taking could happen. You have a finite time before those warrants expire worthless or you decide to exercise the warrants--it's riskier, though offers a higher return. In contrast, you can just hold onto the stock.

Show full opinionHide full opinion
CloudMD (DOC-X)
September 1, 2020

WELL Health vs. Cloud MD, and buy the warrants? Different companies in the same sector. He owns both and expects both to excel in the coming year. Cloud MD just released earnings, not as strong as he expected, but talked about future catalysts coming in the fall. WELL just announced an acquisition and got financing from their biggest shareholder, Lee Ka-Shing. Both are equally good. Warrants: you could do this, but the challenge is that both stocks have enjoyed huge runs and profit-taking could happen. You have a finite time before those warrants expire worthless or you decide to exercise the warrants--it's riskier, though offers a higher return. In contrast, you can just hold onto the stock.

BUY
BUY
July 2, 2020
They should be able to capitalize well on the COVID trend and then the telemedicine trend that will go on. CloudMD has an interesting platform. The stock has not done much in the last 6 weeks. They completed a financing. He suspects people were subscribing and then selling the stock and holding the warrant. He thinks it will continue to do well over the next two years.
Show full opinionHide full opinion
CloudMD (DOC-X)
July 2, 2020
They should be able to capitalize well on the COVID trend and then the telemedicine trend that will go on. CloudMD has an interesting platform. The stock has not done much in the last 6 weeks. They completed a financing. He suspects people were subscribing and then selling the stock and holding the warrant. He thinks it will continue to do well over the next two years.
WATCH
WATCH
June 3, 2020
Tele-medicine? He likes this space. When they looked at what sectors will benefit post-pandemic, this was one. PM Trudeau has committed to putting government money into this space. What worries him about Canadian holdings, is that they are small fish in a big pond. Other companies already have over 50 million subscribers. Valuations are pretty stretched, so he would watch for good opportunities.
Show full opinionHide full opinion
CloudMD (DOC-X)
June 3, 2020
Tele-medicine? He likes this space. When they looked at what sectors will benefit post-pandemic, this was one. PM Trudeau has committed to putting government money into this space. What worries him about Canadian holdings, is that they are small fish in a big pond. Other companies already have over 50 million subscribers. Valuations are pretty stretched, so he would watch for good opportunities.
BUY
BUY
May 27, 2020
A past Top Pick. He likes them for their virtual health care service offerings during and after the pandemic. They just signed a deal to put kiosks in pharmacies. They had an equity offering that was 8 times over-subscribed.
Show full opinionHide full opinion
CloudMD (DOC-X)
May 27, 2020
A past Top Pick. He likes them for their virtual health care service offerings during and after the pandemic. They just signed a deal to put kiosks in pharmacies. They had an equity offering that was 8 times over-subscribed.
TOP PICK
TOP PICK
April 27, 2020

They can take advantage of COVID. They do telemedicine. They are just starting to get adoption.

Show full opinionHide full opinion
CloudMD (DOC-X)
April 27, 2020

They can take advantage of COVID. They do telemedicine. They are just starting to get adoption.

Showing 1 to 5 of 5 entries
  • «
  • 1
  • »

CloudMD(DOC-X) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 3

Stockchase rating for CloudMD is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

CloudMD(DOC-X) Frequently Asked Questions

What is CloudMD stock symbol?

CloudMD is a Canadian stock, trading under the symbol DOC-X on the TSX Venture Exchange (DOC-CV). It is usually referred to as TSXV:DOC or DOC-X

Is CloudMD a buy or a sell?

In the last year, 3 stock analysts published opinions about DOC-X. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for CloudMD.

Is CloudMD a good investment or a top pick?

CloudMD was recommended as a Top Pick by Bruce Campbell (2) on 2020-09-01. Read the latest stock experts ratings for CloudMD.

Why is CloudMD stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is CloudMD worth watching?

3 stock analysts on Stockchase covered CloudMD In the last year. It is a trending stock that is worth watching.

What is CloudMD stock price?

On 2020-09-25, CloudMD (DOC-X) stock closed at a price of $2.09.